HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Helen of Troy

This article was originally published in The Rose Sheet

Executive Summary

Increased focus on wholesale business within personal products segment has "stabilized or at least created a core business in Tactica and left us with less volatility," Senior VP, Chief Financial Officer Russell Gibson tells analysts Oct. 10. Wholesale advances in Tactica, which markets Epil-Stop and IGIA brands, were offset by significant drop in direct response sales, leading to 35% decline in overall division revenue in fiscal second quarter ended Aug. 31, exec notes. Drop was "almost entirely attributable" to reduced sales of Epil-Stop in direct response channel, Gibson says. Firm's consolidated sales fell 1.4% to $111 mil. in Q2, while net income jumped 22% to $8.9 mil. due to cost control initiatives. Full "ramp up" of Clairol brands to be acquired through agreement with P&G will take at least six months, company states. Completion of deal, which covers six hair and skin care brands, is expected within 90 days (1"The Rose Sheet" Sept. 30, 2002, p. 3)...

You may also be interested in...



Helen Of Troy Personal Product Sales To Top $150 Mil. With Clairol Brands

Hair and body care appliance marketer Helen of Troy will build its personal product sales to over $150 mil. with the acquisition of six hair and skin care brands from Procter & Gamble that were previously owned by Clairol

Seretide Settlement To Lift Glenmark’s Europe Business

Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.

US/India Operation Intercepts Unapproved Drugs, Drug/Device Products

Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.

UsernamePublicRestriction

Register

RS010667

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel